The only concern I have is the purchase price. Based on those examples, I think we are looking at $75M to $150M if a buyout were to happen in the short term at or around the time of phase I trials. This would yield a pps of around 8 cents at the high end. I am hoping better returns then that. But, I guess I shouldn't be greedy.

DSUS -